Cutler Group’s Alignment Healthcare ALHC Stock Holding History

Cutler Group’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-500	Closed	-$7K	–	5235
2021 Q4	$7K	Buy	+500	New	+$8.76K	﹤0.01%	3932

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's ALHC Position: Q1 2022 in Review

Cutler Group sold out of Alignment Healthcare (ALHC) in Q1 2022, closing a stake of 500 shares — an estimated $7K sold.

Cutler Group first reported a position in ALHC in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 90 funds tracked by Wall St. Rank hold ALHC as of Q1 2022.

Cutler Group reported no remaining Alignment Healthcare position as of Q1 2022 after selling out during the quarter.
Cutler Group sold 500 Alignment Healthcare shares in Q1 2022, an estimated $7K.
Cutler Group first reported a position in Alignment Healthcare in Q4 2021 and held it in 1 quarter.
Cutler Group's Alignment Healthcare position peaked at $7K in Q4 2021.
90 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.